Evidence map›Paper›PMID 40267108›Full record

ArticlePLoS neglected tropical diseases2025

Left ventricular reverse remodeling: A predictor of survival in chagasic cardiomyopathy patients with a reduced ejection fraction.

Maria Tereza Sampaio de Sousa Lira, Silas Ramos Furquim, Daniel Catto de Marchi, Pamela Camara Maciel, Rafael Cavalcanti Tourinho Dantas, Bruno Biselli, Paulo Roberto Chizzola, Robinson Tadeu Munhoz, Felix José Alvarez Ramires, Barbara Maria Ianni and 4 more

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Maria Tereza Sampaio de Sousa LiraInstituto do Coração (InCor), Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, SP, Brazil.ORCID 0000-0002-7906-1193
Silas Ramos FurquimInstituto do Coração (InCor), Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, SP, Brazil.
Daniel Catto de MarchiInstituto do Coração (InCor), Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, SP, Brazil.
Pamela Camara MacielInstituto do Coração (InCor), Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, SP, Brazil.
Rafael Cavalcanti Tourinho DantasInstituto do Coração (InCor), Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, SP, Brazil.
Bruno BiselliInstituto do Coração (InCor), Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, SP, Brazil.
Paulo Roberto ChizzolaInstituto do Coração (InCor), Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, SP, Brazil.
Robinson Tadeu MunhozInstituto do Coração (InCor), Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, SP, Brazil.
Felix José Alvarez RamiresInstituto do Coração (InCor), Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, SP, Brazil.
Barbara Maria IanniInstituto do Coração (InCor), Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, SP, Brazil.
Fábio FernandesInstituto do Coração (InCor), Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, SP, Brazil.
Silvia Moreira Ayub-FerreiraInstituto do Coração (InCor), Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, SP, Brazil.
Eduardo Gomes LimaInstituto do Coração (InCor), Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, SP, Brazil.
Edimar Alcides BocchiInstituto do Coração (InCor), Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, SP, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChagas disease is a major health issue in Latin America and is now spreading globally because of migration. Chronic Chagasic cardiomyopathy (CCC) leads to heart failure with a reduced ejection fraction (HFrEF). Left ventricular reverse remodeling (LVRR), defined as an improved LVEF, is associated with improved outcomes in patients with other HFrEF etiologies. Therefore, we evaluated the relationship between LVRR and survival in CCC patients with an LVEF<40%.

methodsThis retrospective, single-center study included patients diagnosed with CCC and LVEF<40% between January 2006 and September 2021. Patients were divided into two groups: positive RR (PRR; LVEF≥40% or an absolute LVEF increase of ≥ 10%) and negative RR (NRR). Propensity score matching (PSM) was used to account for baseline differences, and Cox proportional hazards models were applied to determine independent predictors of mortality and heart transplantation.

resultsA total of 1,043 patients were evaluated; 221 (21.2%) were classified as having PRR, and 822 (78.8%) were classified as having NRR. PRR status was associated with a 55% lower risk of all-cause mortality and heart transplantation over 15 years (p = 0.002). Multivariate Cox analysis revealed that predictors of total mortality and heart transplantation included NRR status, a worse NYHA class, lower serum sodium levels, larger LV dimensions, and moderate-to-severe tricuspid regurgitation (TR). The PRR predictors were smaller LV dimensions, less mitral regurgitation, and the absence of triple therapy at baseline. NRR patients were more likely to be on triple therapy at baseline.

conclusionsPRR improves survival in CCC patients with HFrEF. Identifying patients with potential for LVRR, alongside early therapeutic interventions, may reduce mortality in this population. Future research should focus on therapies that promote LVRR in patients with CCC.

Indexed as

Chagas CardiomyopathyStroke VolumeVentricular RemodelingAdultAgedFemaleHeart FailureHeart TransplantationHumansMaleMiddle AgedRetrospective Studies

Identifiers

PMID40267108
PMCPMC12064014

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.